Bertrand Talbotier appointed Senior Advisor of Kurt Salmon’s Life Sciences branch

Kurt Salmon, a global management consulting firm, has announced its collaboration with Bertrand Talbotier, who will contribute his expertise, as a Senior Advisor, to the Life Sciences branch.

Having achieved an Industrial Pharmacy DESS (postgraduate degree), in addition to a Marketing Intelligence Masters at HEC (business school), Bertrand Talbotier has 25 years of industry and consulting experience.

His career began with Sanofi, where he held various roles within the Marketing and General Management departments (Paris, Thailand and Hong Kong), including Vice President of French Marketing. As a member of Sanofi’s management board, he made a significant contribution to the merger of Sanofi and Aventis. Bertrand Talbotier also has experience as an entrepreneur. In 2006, he founded his own consulting firm specializing in health care.

During his career, he has assisted with the creation of strategic alliances between various players in the pharmaceutical and health care industries. Further, Bertrand Talbotier chaired a major American health care nonprofit group, BroadReach Healthcare, whose international scope allowed him to influence health care solutions in multicultural environments in Europe, Asia, Africa and the United States.

Bertrand Talbotier is now bringing his skills to Kurt Salmon, where he will assist in developing and strengthening the firm’s dedicated Life Sciences practice (fine chemicals, pharmaceutical industry, cosmetics industry). Kurt Salmon will benefit from his innovative perspective on issues associated with Market Access, Strategic Marketing, Sales Performance, Strategic Alliances and Digital Transformation.

Confronting strategic concerns in a transitional pharmaceutical sector

Historically, the Life Sciences industries, and especially the pharmaceutical industry, were very prosperous, supported by a focused, lucrative “blockbuster” model. The pharmaceutical industry must now address constant pressures associated with turnover and profits. Increasing regulation, growing competition from bio-similar drugs, and the development of biotechnologies are just a few factors the pharmaceutical industry must take into account.

Companies must now develop new, hybrid strategies to address new obligations, such as diversifying their portfolio of products, adopting an extremely targeted approach, focusing on the needs of patients and all health care players and adapting to the significant challenge posed by emerging economies.

“Joining Kurt Salmon and providing an innovative perspective on the current transition in the sector is an exciting challenge in this pivotal period. Many major players in Life Sciences are questioning their future strategies and believe that in order to overcome these numerous challenges, they must adapt their business model. To stand alongside our clients and partners is a vital responsibility and our role is to guide them along a path which will allow them to accelerate their transformation and support innovation, which now, more than ever, is a pressing requirement,” explains Bertrand Talbotier.

“Kurt Salmon has developed significant expertise in optimizing industrial performance, transforming support functions and corporate operations within the Life Sciences sector. The firm is now growing and assisting companies in the sector with strategic concerns, which include market development, strategic alliances and sales performance,” adds Bernard Desprez, Chief Executive Officer at Kurt Salmon

About Kurt Salmon

Kurt Salmon is a consulting firm that provides transformation services to companies across a variety of industries. Kurt Salmon’s 1,200 employees provide company executives with consulting services and innovative ideas which have a direct and concrete impact on the success of their projects and, specifically, on their transformation projects. Kurt Salmon assists executives when exploring new trajectories for their companies. Our consulting teams work alongside our clients in order to better understand their market expectations, help them discern development factors in their business sector and identify a competitive and differentiated strategy which will allow them to demonstrate their leadership.

www.kurtsalmon.com

To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.

Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20150203005283/en/

Contact information

WELLCOM
Sonia El Ouardi /Marianne Felce-Dachez
Press Relations
+33 1 46 34 60 60
se@wellcom.fr / mfd@wellcom.fr
or
Kurt Salmon
Marie-Claire Daunis
Press Relations
+33 4 72 82 52 16
marie-claire.daunis@kurtsalmon.com